Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alentis Therapeutics
Biotech
BIO announces new CEO—Chutes & Ladders
BIO lands rare disease advocate John Crowley as CEO. Cyclerion Therapeutics picks EQRx leader for top spot. Sensorium selects new CEO.
Gabrielle Masson
,
Annalee Armstrong
Dec 8, 2023 9:30am
Alentis secures $105M series C for anti-fibrotic ambitions
Apr 13, 2023 1:00am
New year, new C-suite execs—Chutes & Ladders
Jan 6, 2023 9:30am
Biogen CEO steps down after Aduhelm blunder—Chutes & Ladders
May 6, 2022 9:30am
Sanofi-backed Jeito snags $630M fund for 12-15 European biotechs
Sep 20, 2021 1:00am
Alentis nabs $67M to enter clinic by year-end for anti-fibrotic
Jun 15, 2021 1:00am